Brief: Vitrolife Q3 EBITDA Down At SEK 134 Mln
Nov 6 (Reuters) - Vitrolife AB VITR.ST :
* INTERIM REPORT JANUARY - SEPTEMBER 2020: GOOD
PROFITABILITY AND
CONTINUED RECOVERY
* Q3 SALES SEK 320 MILLION VERSUS SEK 378 MILLION YEAR AGO
* Q3 EBITDA SEK 134 MILLION VERSUS SEK 155 MILLION YEAR AGO
* SALES WERE NEGATIVELY IMPACTED BY COVID-19 AS A RESULT OF
REDUCED DEMAND
Source text for Eikon: ID:nWkr1r8SqM
Further company coverage: VITR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))